Heat-killed Mycobacterium paragordonae therapy exerts an anti-cancer immune response via enhanced immune cell mediated oncolytic activity in xenograft mice model
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 472, 142-150
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology (NRF- 2019R1F1A1060196)
- Seoul National University Hospital (0420190230)
This publication has 39 references indexed in Scilit:
- Activation of Anti-Tumor Immune Response and Reduction of Regulatory T Cells with Mycobacterium indicus pranii (MIP) Therapy in Tumor Bearing MicePLOS ONE, 2011
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor ImmunityCancer Research, 2010
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer ModelPLOS ONE, 2009
- Antigen Presented by TumorsIn vivoDetermines the Nature of CD8+ T-Cell CytotoxicityCancer Research, 2009
- Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton StimulationClinical Cancer Research, 2006
- Cancer Immunotherapy Based on Killing of Salmonella-Infected Tumor CellsCancer Research, 2005
- The role of apoptosis in cancer development and treatment responseNature Reviews Cancer, 2005
- NK cell and DC interactionsTrends in Immunology, 2004
- Therapeutic potential of mycobacterial cell wall-DNA complexesExpert Opinion on Investigational Drugs, 2001
- Therapeutic effect of intratumoral injection of BCG and other substances in rats and miceInternational Journal of Cancer, 1975